Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: Current advances

Biotechnology Advances

Volumn 29, Issue 6, 2011, Pages 869-878

  Vicente, Tiago ^a,b   Mota, José P B ^c   Peixoto, Cristina ^a   Alves, Paula M ^a,b   Carrondo, Manuel J T ^a,b,c  

^a IBET   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Analytical technologies; Ion exchange chromatography; Mathematical model; Membrane processes; Viral vector; Virus like particle

Indexed keywords

ANALYTICAL TECHNOLOGY; ION-EXCHANGE CHROMATOGRAPHY; MEMBRANE PROCESSES; VIRAL VECTORS; VIRUS-LIKE PARTICLES;

CELL CULTURE; DESIGN; INDUSTRIAL RESEARCH; ION EXCHANGE; KNOWLEDGE BASED SYSTEMS; MATHEMATICAL MODELS; OPTIMIZATION; SURFACE PLASMON RESONANCE; VIRUSES;

CHROMATOGRAPHY;

ADVANCED TECHNOLOGY; ANALYTICAL METHOD; BIOTECHNOLOGY; CANCER; DISEASE TREATMENT; DRUG; ION CHROMATOGRAPHY; ION EXCHANGE; MANUFACTURING; MEMBRANE; NUMERICAL MODEL; OPTIMIZATION; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT; SCIENCE AND TECHNOLOGY; VIRUS;

CHEMISTRY; GENE VECTOR; ION EXCHANGE CHROMATOGRAPHY; METHODOLOGY; PHARMACEUTICS; REVIEW; VIRION;

BIOPHARMACEUTICS; CHROMATOGRAPHY, ION EXCHANGE; GENETIC VECTORS; TECHNOLOGY, PHARMACEUTICAL; VIRION;

EID: 80053444587     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2011.07.004     Document Type: Review

References (117)

1. Aboud M., Wolfson M., Hassan Y., Huleihel M. Rapid purification of extracellular and intracellular moloney murine leukemia virus. Arch Virol 1982, 71:185-195.
2. Ayuso E., Mingozzi F., Montane J., Leon X., Anguela X.M., Haurigot V., et al. High aav vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther 2010, 17:503-510.
3. Barsoum J. Concentration of recombinant baculovirus by cation-exchange chromatography. Biotechniques 1999, 26:834-836.
4. Branovic K., Forcic D., Ivancic J., Strancar A., Barut M., Kosutic-Gulija T., et al. Application of short monolithic columns for improved detection of viruses. J Virol Methods 2003, 110:163-171.
5. Brooks C.A., Cramer S.M. Steric mass-action ion exchange: displacement profiles and induced salt gradients. AIChE J 1992, 38:1969-1978.
6. Buckland B.C. The process development challenge for a new vaccine. Nat Med 2005, 11:S16-S19.
7. Carmo M., Dias J.D., Panet A., Coroadinha A.S., Carrondo M.J.T., Alves P.M., et al. Thermosensitivity of the reverse transcription process as an inactivation mechanism of lentiviral vectors. Hum Gene Ther 2009, 20:1168-1176.
8. Chahal P.S., Aucoin M.G., Kamen A. Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. J Virol Methods 2007, 139:61-70.
9. Charcosset C. Membrane processes in biotechnology: an overview. Biotechnol Adv 2006, 24:482-492.
10. Chen G.Y., Chen C.Y., Chang M.D.T., Matsuura Y., Hu Y.C. Concanavalin a affinity chromatography for efficient baculovirus purification. Biotechnol Prog 2009, 25:1669-1677.
11. Coffman J.L., Kramarczyk J.F., Kelley B.D. High-throughput screening of chromatographic separations: I. method development and column modeling. Biotechnol Bioeng 2008, 100:605-618.
12. Cook J.C., Joyce J.G., George H.A., Schultz L.D., Hurni W.M., Jansen K.U., et al. Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein l1 from saccharomyces cerevisiae. Protein Expr Purif 1999, 17:477-484.
13. Cox M.M.J. Cell-based protein vaccines for influenza. Curr Opin Mol Ther 2005, 7:24-29.
14. Crommelin D.J.A., Storm G., Verrijk R., de Leede L., Jiskoot W., Hennink W.E. Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. Int J Pharm 2003, 266:3-16. A Special Issue for Professor Hans E. Junginger on the occasion of his 60th birthday.
15. Cruz P.E., Maranga L., Carrondo M.J.T. Integrated process optimization: lessons from retrovirus and virus-like particle production. J Biotechnol 2002, 99:199-214.
16. Davidoff A.M., Ng C.Y., Sleep S., Gray J., Azam S., Zhao Y., et al. Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. J Virol Methods 2004, 121:209-215.
17. Debelak D., Fisher J., Iuliano S., Sesholtz D., Sloane D.L., Atkinson E.M. Cation-exchange high-performance liquid chromatography of recombinant adeno-associated virus type 2. J Chromatogr B Biomed Sci Appl 2000, 740:195-202.
18. Dismer F., Hubbuch J. A novel approach to characterize the binding orientation of lysozyme on ion-exchange resins. J Chromatogr A 2007, 1149:312-320.
19. Dismer F., Hubbuch J. 3d structure-based protein retention prediction for ion-exchange chromatography. J Chromatogr A 2010, 1217:1343-1353.
20. Dismer F., Petzold M., Hubbuch J. Effects of ionic strength and mobile phase ph on the binding orientation of lysozyme on different ion-exchange adsorbents. J Chromatogr A 2008, 1194:11-21.
21. Dormond E., Chahal P., Bernier A., Tran R., Perrier M., Kamen A. An efficient process for the purification of helper-dependent adenoviral vector and removal of helper virus by iodixanol ultracentrifugation. J Virol Methods 2010, 165:83-89.
22. EDQM European pharmacopoeia: 5.14. Gene transfer medicinal products for human use 2011.
23. EDQM European pharmacopoeia: Human papillomavirus vaccine (rDNA) 2011.
24. Etzel M.R., Riordan W.T. Viral clearance using monoliths. J Chromatogr A 2009, 1216:2621-2624.
25. FDA Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications 2010.
26. FDA Guidance for industry: potency tests for cellular and gene therapy products 2010.
27. Ferguson S.D., Ahmed A.U., Thaci B., Mercer R.W., Lesniak M.S. Crossing the boundaries: stem cells and gene therapy. Discov Med 2010, 9:192-196.
28. Fontes N., van Reis R. Advances in technology and process development for industrial-scale monoclonal antibody purification. Process scale purification of antibodies 2009, 203-221. John Wiley & Sons. U. Gottschalk (Ed.).
29. Gotoh T., Miyazaki Y., Sato W., Kikuchi K., Bentley W.E. Proteolytic activity and recombinant protein production in virus-infected sf-9 insect cell cultures supplemented with carboxyl and cysteine protease inhibitors. J Biosci Bioeng 2001, 92:248-255.
30. Gottschalk U. Bioseparation in antibody manufacturing: the good, the bad and the ugly. Biotechnol Prog 2008, 24:496-503.
31. Grzenia D.L., Carlson J.O., Czermak P., Han B., Specht R.K., Wickramasinghe S.R. Purification of densonucleosis virus by tangential flow ultrafiltration. Biotechnol Prog 2006, 22:1346-1353.
32. Grzenia D.L., Carlson J.O., Wickramasinghe S.R. Tangential flow filtration for virus purification. J Membr Sci 2008, 321:373-380.
33. Gutiérrez-Aguirre I., Banjac M., Steyer A., Poljsak-Prijatelj M., Peterka M., Strancar A., et al. Concentrating rotaviruses from water samples using monolithic chromatographic supports. J Chromatogr A 2009, 1216:2700-2704.
34. Hanslip S., Zaccai N., Middelberg A., Falconer R. Assembly of human papillomavirus type-16 virus-like particles: multifactorial study of assembly and competing aggregation. Biotechnol Prog 2006, 22:554-560.
35. Hjorth R. Expanded-bed adsorption in industrial bioprocessing: recent developments. Trends Biotechnol 1997, 15:230-235.
36. Jiang C., Wechuck J.B., Goins W.F., Krisky D.M., Wolfe D., Ataai M.M., et al. Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. J Virol 2004, 78:8994-9006.
37. Jungbauer A., Hahn R. Polymethacrylate monoliths for preparative and industrial separation of biomolecular assemblies. J Chromatogr A 2008, 1184:62-79.
38. Kalbfuss B., Wolff M., Geisler L., Tappe A., Wickramasinghe R., Thom V., et al. Direct capture of influenza a virus from cell culture supernatant with sartobind anion-exchange membrane adsorbers. J Membr Sci 2007, 299:251-260.
39. Kaludov N., Handelman B., Chiorini J.A. Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum Gene Ther 2002, 13:1235-1243.
40. Kang S.M., Pushko P., Bright R.A., Smith G., Compans R.W. Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol 2009, 333:269-289.
41. Kelley B., Blank G., Lee A. Downstream processing of monoclonal antibodies: current practices and future opportunities. Process scale purification of antibodies 2009, 1-23. John Wiley & Sons. U. Gottschalk (Ed.).
42. Kelner D., Bhalgat M. Analytical strategy for biopharmaceutical development. Process scale bioseparations for the biopharmaceutical industry 2007, Taylor and Francis. A. Shukla, M.R. Etzel, S. Gadam (Eds.).
43. Kokpinar O., Harkensee D., Kasper C., Scheper T., Zeidler R., Reif O.W., et al. Innovative modular membrane adsorber system for high-throughput downstream screening for protein purification. Biotechnol Prog 2006, 22:1215-1219.
44. Konz J.O., Lee A.L., Lewis J.A., Sagar S.L. Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell dna. Biotechnol Prog 2005, 21:466-472.
45. Konz J.O., Pitts L.R., Sagar S.L. Scaleable purification of adenovirus vectors. Methods Mol Biol 2008, 434:13-23.
46. Kramberger P., Petrovic N., Strancar A., Ravnikar M. Concentration of plant viruses using monolithic chromatographic supports. J Virol Methods 2004, 120:51-57.
47. Kroeber T., Knoechlein A., Eisold K., Kalbfuss-Zimmermann B., Reichl U. Dna depletion by precipitation in the purification of cell culture-derived influenza vaccines. Chem Eng Technol 2010, 33:941-959.
48. Kuiper M., Sanches R.M., Walford J.A., Slater N.K. Purification of a functional gene therapy vector derived from moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography. Biotechnol Bioeng 2002, 80:445-453.
49. Kutner R.H., Zhang X.Y., Reiser J. Production, concentration and titration of pseudotyped hiv-1-based lentiviral vectors. Nat Protoc 2009, 4:495-505.
50. Ladiwala A., Rege K., Breneman C.M., Cramer S.M. A priori prediction of adsorption isotherm parameters and chromatographic behavior in ion-exchange systems. Proc Natl Acad Sci USA 2005, 102:11710-11715.
51. Lesch H.P., Turpeinen S., Niskanen E.A., Mähönen A.J., Airenne K.J., Ylä-Herttuala S. Generation of lentivirus vectors using recombinant baculoviruses. Gene Ther 2008, 15:1280-1286.
52. Lewis G.D., Metcalf T.G. Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis a virus and human rotavirus, from oyster, water, and sediment samples. Appl Environ Microbiol 1988, 54:1983-1988.
53. Li Y., Kahn D.W., Galperina O., Blatter E., Luo R., Wu Y., et al. Development of a platform process for the purification of therapeutic monoclonal antibodies. Process scale purification of antibodies 2009, 187-201. John Wiley & Sons. U. Gottschalk (Ed.).
54. Lightfoot E.N., Moscariello J.S. Bioseparations. Biotechnol Bioeng 2004, 87:259-273.
55. Lusky M. Good manufacturing practice production of adenoviral vectors for clinical trials. Hum Gene Ther 2005, 16:281-291.
56. Lyddiatt A. Process chromatography: current constraints and future options for the adsorptive recovery of bioproducts. Curr Opin Biotechnol 2002, 13:95-103.
57. Mach H., Volkin D.B., Troutman R.D., Wang B., Luo Z., Jansen K.U., et al. Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (hpv vlps). J Pharm Sci 2006, 95:2195-2206.
58. Maranga L., Rueda P., Antonis A.F., Vela C., Langeveld J.P., Casal J.I., et al. Large scale production and downstream processing of a recombinant porcine parvovirus vaccine. Appl Microbiol Biotechnol 2002, 59:45-50.
59. Mellado M.C., Peixoto C., Cruz P.E., Carrondo M.J., Alves P.M. Purification of recombinant rotavirus vp7 glycoprotein for the study of in vitro rotavirus-like particles assembly. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 874:89-94.
60. Mellado M.C.M., Mena J.A., Lopes A., Ramírez O.T., Carrondo M.J.T., Palomares L.A., et al. Impact of physicochemical parameters on in vitro assembly and disassembly kinetics of recombinant triple-layered rotavirus-like particles. Biotechnol Bioeng 2009, 104:674-686.
61. Merten O.W., Geny-Fiamma C., Douar A.M. Current issues in adeno-associated viral vector production. Gene Ther 2005, 12:S51-S61.
62. Mollerup J.M., Hansen T.B., Kidal S., Staby A. Quality by design - thermodynamic modelling of chromatographic separation of proteins. J Chromatogr A 2008, 1177:200-206.
63. Morenweiser R. Downstream processing of viral vectors and vaccines. Gene Ther 2005, 12(Suppl. 1):S103-S110.
64. Morling F., Russell S. Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate. Gene Ther 1995, 2:504-508.
65. Nayak D.P., Lehmann S., Reichl U. Downstream processing of mdck cell-derived equine influenza virus. J Chromatogr B Analyt Technol Biomed Life Sci 2005, 823:75-81.
66. Nfor B.K., Verhaert P.D.E.M., van der Wielen L.A.M., Hubbuch J., Ottens M. Rational and systematic protein purification process development: the next generation. Trends Biotechnol 2009, 27:673-679.
67. O'Riordan C.R., Lachapelle A.L., Vincent K.A., Wadsworth S.C. Scaleable chromatographic purification process for recombinant adeno-associated virus (raav). J Gene Med 2000, 2:444-454.
68. Okada T., Nonaka-Sarukawa M., Uchibori R., Kinoshita K., Hayashita-Kinoh H., Nitahara-Kasahara Y., et al. Scalable purification of adeno-associated virus serotype 1 (aav1) and aav8 vectors, using dual ion-exchange adsorptive membranes. Hum Gene Ther 2009, 20:1013-1021.
69. Opitz L., Salaklang J., Buttner H., Reichl U., Wolff M.W. Lectin-affinity chromatography for downstream processing of mdck cell culture derived human influenza a viruses. Vaccine 2007, 25:939-947.
70. Opitz L., Zimmermann A., Lehmann S., Genzel Y., Lübben H., Reichl U., et al. Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent. J Virol Methods 2008, 154:61-68.
71. Peixoto C., Ferreira T., Carrondo M., Cruz P., Alves P. Purification of adenoviral vectors using expanded bed chromatography. J Virol Methods 2006, 132:121-126.
72. Peixoto C., Sousa M.F.Q., Silva A.C., Carrondo M.J.T., Alves P.M. Downstream processing of triple layered rotavirus like particles. J Biotechnol 2007, 127:452-461.
73. Peixoto C., Ferreira T.B., Sousa M.F.Q., Carrondo M.J.T., Alves P.M. Towards purification of adenoviral vectors based on membrane technology. Biotechnol Prog 2008, 24:1290-1296.
74. Prashad M., Tarrach K. Depth filtration: cell clarification of bioreactor offloads. Filtr Sep 2006, 43:28-30.
75. Przybycien T.M., Pujar N.S., Steele L.M. Alternative bioseparation operations: life beyond packed-bed chromatography. Curr Opin Biotechnol 2004, 15:469-478.
76. Pujar N.S., Zydney A.L. Electrostatic effects on protein partitioning in size-exclusion chromatography and membrane ultrafiltration. J Chromatogr A 1998, 796:229-238.
77. Rege K., Pepsin M., Falcon B., Steele L., Heng M. High-throughput process development for recombinant protein purification. Biotechnol Bioeng 2006, 93:618-630.
78. Rodrigues T., Carvalho A., Roldao A., Carrondo M.J.T., Alves P.M., Cruz P.E. Screening anion-exchange chromatographic matrices for isolation of onco-retroviral vectors. J Chromatogr B 2006, 837:59-68.
79. Rodrigues T., Carrondo M.J.T., Alves P.M., Cruz P.E. Purification of retroviral vectors for clinical application: biological implications and technological challenges. J Biotechnol 2007, 127:520-541.
80. Rodrigues T., Carvalho A., Carmo M., Carrondo M., Alves P., Cruz P. Scaleable purification process for gene therapy retroviral vectors. J Gene Med 2007, 9:233-243.
81. Rodrigues T., Alves A., Lopes A., Carrondo M.J., Alves P.M., Cruz P.E. Removal of envelope protein-free retroviral vectors by anion-exchange chromatography to improve product quality. J Sep Sci 2008, 31:3509-3518.
82. Rodriguez-Limas W.A., Tyo K.E.J., Nielsen J., Ramirez O.T., Palomares L.A. Molecular and process design for rotavirus-like particle production in saccharomyces cerevisiae. Microb Cell Fact 2011, 10:33.
83. Roldão A., Mellado M.C.M., Castilho L.R., Carrondo M.J.T., Alves P.M. Virus-like particles in vaccine development. Expert Rev Vaccines 2010, 9:1149-1176.
84. Roper D.K. Determining surface plasmon resonance response factors for deposition onto three-dimensional surfaces. Chem Eng Sci 2007, 62:1988-1996.
85. Roper D.K., Nakra S. Adenovirus type 5 intrinsic adsorption rates measured by surface plasmon resonance. Anal Biochem 2006, 348:75-83.
86. Saha K., Lin Y.C., Wong P.K. A simple method for obtaining highly viable virus from culture supernatant. J Virol Methods 1994, 46:349-352.
87. Schaldach C.M., Bourcier W.L., Shaw H.F., Viani B.E., Wilson W.D. The influence of ionic strength on the interaction of viruses with charged surfaces under environmental conditions. J Colloid Interface Sci 2006, 294:1-10.
88. Schubert S., Freitag R. Investigation of the interaction mechanism of the recombinant human antibody mdj8 and its fragments with chromatographic apatite phases. J Chromatogr A 2009, 1216:3831-3840.
89. Shukla A., Kandula J. Harvest and recovery of monoclonal antibodies: cell removal and clarification. Process scale purification of antibodies 2009, 53-78. John Wiley & Sons. U. Gottschalk (Ed.).
90. Shukla A.A., Hubbard B., Tressel T., Guhan S., Low D. Downstream processing of monoclonal antibodies - application of platform approaches. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 848:28-39.
91. Smith R.H., Yang L., Kotin R.M. Chromatography-based purification of adeno-associated virus. Methods Mol Biol 2008, 434:37-54.
92. Specht R., Han B., Wickramasinghe S.R., Carlson J.O., Czermak P., Wolf A., et al. Densonucleosis virus purification by ion exchange membranes. Biotechnol Bioeng 2004, 88:465-473.
93. Trilisky E.I., Lenhoff A.M. Sorption processes in ion-exchange chromatography of viruses. J Chromatogr A 2007, 1142:2-12.
94. Trilisky E.I., Lenhoff A.M. Flow-dependent entrapment of large bioparticles in porous process media. Biotechnol Bioeng 2009, 104:127-133.
95. Trilisky E.I., Koku H., Czymmek K.J., Lenhoff A.M. Relation of structure to performance characteristics of monolithic and perfusive stationary phases. J Chromatogr A 2009, 1216:6365-6376.
96. Tsoka S., Ciniawskyj O.C., Thomas O.R.T., Titchener-Hooker N.J., Hoare M. Selective flocculation and precipitation for the improvement of virus-like particle recovery from yeast homogenate. Biotechnol Prog 2000, 16:661-667.
97. van Reis R., Zydney A. Bioprocess membrane technology. J Membr Sci 2007, 297:16-50.
98. van Reis R., Gadam S., Frautschy L.N., Orlando S., Goodrich E.M., Saksena S., et al. High performance tangential flow filtration. Biotechnol Bioeng 1997, 56:71-82.
99. Vellekamp G., Porter F.W., Sutjipto S., Cutler C., Bondoc L., Liu Y.H., et al. Empty capsids in column-purified recombinant adenovirus preparations. Hum Gene Ther 2001, 12:1923-1936.
100. Vicente T., Sousa M.F.Q., Peixoto C., Mota J.P.B., Alves P.M., Carrondo M.J.T. Anion-exchange membrane chromatography for purification of rotavirus-like particles. J Membr Sci 2008, 311:270-283.
101. Vicente T., Peixoto C., Carrondo M.J.T., Alves P.M. Purification of recombinant baculoviruses for gene therapy using membrane processes. Gene Ther 2009, 16:766-775.
102. Vicente T., Peixoto C., Carrondo M.J.T., Alves P.M. Virus production for clinical gene therapy. Methods Mol Biol 2009, 542:447-470.
103. Vicente T., Mota J.P.B., Peixoto C., Alves P.M., Carrondo M.J.T. Analysis of adsorption of a baculovirus bioreaction bulk on an ion-exchange surface by surface plasmon resonance. J Biotechnol 2010, 148:171-181.
104. Vicente T., Mota J.P.B., Peixoto C., Alves P.M., Carrondo M.J.T. Modeling protein binding and elution over a chromatographic surface probed by surface plasmon resonance. J Chromatogr A 2010, 1217:2032-2041.
105. Vicente T., Peixoto C., Alves P.M., Carrondo M.J.T. Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development. J Chromatogr A 2010, 1217:3754-3764.
106. Vicente T., Faber R., Alves P.M., Carrondo M.J.T., Mota J.P.B. Impact of ligand density on the optimization of ion-exchange membrane chromatography for viral vector purification. Biotechnol Bioeng 2011, 108:1347-1359.
107. Vieira H.L.A., Estevao C., Roldao A., Peixoto C.C., Sousa M.F.Q., Cruz P.E., et al. Triple layered rotavirus vlp production: kinetics of vector replication, mRNA stability and recombinant protein production. J Biotechnol 2005, 120:72-82.
108. Wensel D.L., Kelley B.D., Coffman J.L. High-throughput screening of chromatographic separations: Iii. monoclonal antibodies on ceramic hydroxyapatite. Biotechnol Bioeng 2008, 100:839-854.
109. Whitfield R.J., Battom S.E., Barut M., Gilham D.E., Ball P.D. Rapid high-performance liquid chromatographic analysis of adenovirus type 5 particles with a prototype anion-exchange analytical monolith column. J Chromatogr A 2009, 1216:2725-2729.
110. Wickramasinghe S.R., Carlson J.O., Teske C., Hubbuch J., Ulbricht M. Characterizing solute binding to macroporous ion exchange membrane adsorbers using confocal laser scanning microscopy. J Membr Sci 2006, 281:609-618.
111. Wickramasinghe S.R., Stump E.D., Grzenia D.L., Husson S.M., Pellegrino J. Understanding virus filtration membrane performance. J Membr Sci 2010, 365:160-169.
112. Wolff M.W., Siewert C., Hansen S.P., Faber R., Reichl U. Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography. Biotechnol Bioeng 2010, 107:312-320.
113. Wright J.F., Le T., Prado J., Bahr-Davidson J., Smith P.H., Zhen Z., et al. Identification of factors that contribute to recombinant aav2 particle aggregation and methods to prevent its occurrence during vector purification and formulation. Mol Ther 2005, 12:171-178.
114. Wu C., Soh K.Y., Wang S. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum Gene Ther 2007, 18:665-672.
115. Yamada K., McCarty D.M., Madden V.J., Walsh C.E. Lentivirus vector purification using anion exchange hplc leads to improved gene transfer. Biotechniques 2003, 34:1074-1078. 1080.
116. Ye K., Jin S., Ataai M.M., Schultz J.S., Ibeh J. Tagging retrovirus vectors with a metal binding peptide and one-step purification by immobilized metal affinity chromatography. J Virol 2004, 78:9820-9827.
117. Zhou J.X., Tressel T., Gottschalk U., Solamo F., Pastor A., Dermawan S., et al. New q membrane scale-down model for process-scale antibody purification. J Chromatogr A 2006, 1134:66-73.